1998
DOI: 10.1001/archpsyc.55.7.618
|View full text |Cite
|
Sign up to set email alerts
|

Does Participation in Psychosocial Treatment Augment the Benefit of Clozapine?

Abstract: Background: This study examines the role of participation in psychosocial treatment as a mediator of the clinical effectiveness of clozapine.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
28
0

Year Published

1999
1999
2009
2009

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 65 publications
(28 citation statements)
references
References 33 publications
(20 reference statements)
0
28
0
Order By: Relevance
“…There were no significant differences in the proportion of patients who completed the entire trial while blinded and receiving study drug (39.3% of patients assigned to haloperidol vs 45.9% assigned to olanzapine; P=. 25) …”
Section: Retentionmentioning
confidence: 93%
“…There were no significant differences in the proportion of patients who completed the entire trial while blinded and receiving study drug (39.3% of patients assigned to haloperidol vs 45.9% assigned to olanzapine; P=. 25) …”
Section: Retentionmentioning
confidence: 93%
“…Such trials are needed to provide proof that enhancing cognitive function via antipsychotic drug treatment really improves psychosocial functioning. Indirect clues that this may be a valid assumption have been provided by Rosenheck et al (1998) and Marder (2000), who have reported that clozapine or risperidone, respectively, improved effects of psychosocial interventions.…”
Section: Methodsmentioning
confidence: 99%
“…16 Rosenheck et al 17 report that clozapine facilitates psychosocial treatment participation, enhancing effects on quality of life and long-term symptom outcome.…”
mentioning
confidence: 99%